GRI Bio Etf Forward View - Simple Moving Average
| GRI Etf | USD 3.26 0.06 1.81% |
GRI Etf outlook is based on your current time horizon. We recommend always using this module together with an analysis of GRI Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
The RSI of GRI Bio's share price is below 30 as of 31st of January 2026. This usually indicates that the etf is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling GRI Bio, making its price go up or down. Momentum 29
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.94) | EPS Estimate Current Year (5.86) | EPS Estimate Next Year (2.03) | Wall Street Target Price 22.5 | EPS Estimate Current Quarter (1.31) |
Using GRI Bio hype-based prediction, you can estimate the value of GRI Bio from the perspective of GRI Bio response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of GRI Bio on the next trading day is expected to be 3.26 with a mean absolute deviation of 2.33 and the sum of the absolute errors of 139.63. GRI Bio after-hype prediction price | USD 2.51 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of GRI Bio to cross-verify your projections. GRI Bio Additional Predictive Modules
Most predictive techniques to examine GRI price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for GRI using various technical indicators. When you analyze GRI charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
GRI Bio Simple Moving Average Price Forecast For the 1st of February
Given 90 days horizon, the Simple Moving Average forecasted value of GRI Bio on the next trading day is expected to be 3.26 with a mean absolute deviation of 2.33, mean absolute percentage error of 22.32, and the sum of the absolute errors of 139.63.Please note that although there have been many attempts to predict GRI Etf prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that GRI Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
GRI Bio Etf Forecast Pattern
| Backtest GRI Bio | GRI Bio Price Prediction | Buy or Sell Advice |
GRI Bio Forecasted Value
In the context of forecasting GRI Bio's Etf value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. GRI Bio's downside and upside margins for the forecasting period are 0.03 and 14.85, respectively. We have considered GRI Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of GRI Bio etf data series using in forecasting. Note that when a statistical model is used to represent GRI Bio etf, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 119.378 |
| Bias | Arithmetic mean of the errors | 1.0712 |
| MAD | Mean absolute deviation | 2.3272 |
| MAPE | Mean absolute percentage error | 0.1229 |
| SAE | Sum of the absolute errors | 139.63 |
Predictive Modules for GRI Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GRI Bio. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.GRI Bio After-Hype Price Density Analysis
As far as predicting the price of GRI Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in GRI Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of GRI Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
GRI Bio Estimiated After-Hype Price Volatility
In the context of predicting GRI Bio's etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on GRI Bio's historical news coverage. GRI Bio's after-hype downside and upside margins for the prediction period are 0.13 and 14.10, respectively. We have considered GRI Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
GRI Bio is very risky at this time. Analysis and calculation of next after-hype price of GRI Bio is based on 3 months time horizon.
GRI Bio Etf Price Outlook Analysis
Have you ever been surprised when a price of a ETF such as GRI Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GRI Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with GRI Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.35 | 11.59 | 2.88 | 0.45 | 4 Events / Month | 6 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.26 | 2.51 | 22.99 |
|
GRI Bio Hype Timeline
On the 31st of January GRI Bio is traded for 3.26. The entity has historical hype elasticity of -2.88, and average elasticity to hype of competition of 0.45. GRI is projected to decline in value after the next headline, with the price expected to drop to 2.51. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -22.99%, whereas the daily expected return is currently at -3.35%. The volatility of related hype on GRI Bio is about 8714.29%, with the expected price after the next announcement by competition of 3.71. The company has price-to-book (P/B) ratio of 0.89. Some equities with similar Price to Book (P/B) outperform the market in the long run. GRI Bio recorded earning per share (EPS) of 90.8. The entity had 1:17 split on the 24th of February 2025. Considering the 90-day investment horizon the next projected press release will be in about 4 days. Check out Historical Fundamental Analysis of GRI Bio to cross-verify your projections.GRI Bio Related Hype Analysis
Having access to credible news sources related to GRI Bio's direct competition is more important than ever and may enhance your ability to predict GRI Bio's future price movements. Getting to know how GRI Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how GRI Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CNSP | CNS Pharmaceuticals | 0.22 | 7 per month | 0.00 | (0.1) | 7.22 | (7.57) | 26.44 | |
| JAGX | Jaguar Animal Health | 0.03 | 9 per month | 0.00 | (0.07) | 9.71 | (16.87) | 125.57 | |
| SILO | Silo Pharma | 0.03 | 27 per month | 0.00 | (0.18) | 8.33 | (10.00) | 24.79 | |
| BDRX | Biodexa Pharmaceticals | 1.55 | 8 per month | 0.00 | (0.05) | 11.45 | (16.09) | 128.35 | |
| ABP | Abpro Holdings | (0.34) | 9 per month | 0.00 | (0.23) | 10.52 | (11.71) | 34.70 | |
| INM | InMed Pharmaceuticals | 0.02 | 8 per month | 0.00 | (0.15) | 7.48 | (9.30) | 30.84 | |
| CANF | Can Fite Biopharma | 0.18 | 9 per month | 0.00 | (0.14) | 10.40 | (8.59) | 38.42 | |
| SXTP | 60 Degrees Pharmaceuticals | (0.17) | 10 per month | 6.79 | 0.04 | 8.57 | (9.92) | 161.92 | |
| GNPX | Genprex | (0.13) | 7 per month | 0.00 | (0.20) | 18.18 | (12.35) | 44.30 | |
| CLDI | Calidi Biotherapeutics | (0.06) | 9 per month | 0.00 | (0.15) | 4.90 | (7.14) | 24.52 |
Other Forecasting Options for GRI Bio
For every potential investor in GRI, whether a beginner or expert, GRI Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. GRI Etf price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in GRI. Basic forecasting techniques help filter out the noise by identifying GRI Bio's price trends.GRI Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GRI Bio etf to make a market-neutral strategy. Peer analysis of GRI Bio could also be used in its relative valuation, which is a method of valuing GRI Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
GRI Bio Market Strength Events
Market strength indicators help investors to evaluate how GRI Bio etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GRI Bio shares will generate the highest return on investment. By undertsting and applying GRI Bio etf market strength indicators, traders can identify GRI Bio entry and exit signals to maximize returns.
| Accumulation Distribution | 22815.31 | |||
| Daily Balance Of Power | (0.15) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 3.41 | |||
| Day Typical Price | 3.36 | |||
| Price Action Indicator | (0.18) | |||
| Period Momentum Indicator | (0.06) | |||
| Relative Strength Index | 29.69 |
GRI Bio Risk Indicators
The analysis of GRI Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in GRI Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting gri etf prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.36 | |||
| Standard Deviation | 11.09 | |||
| Variance | 122.89 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for GRI Bio
The number of cover stories for GRI Bio depends on current market conditions and GRI Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that GRI Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about GRI Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
GRI Bio Short Properties
GRI Bio's future price predictability will typically decrease when GRI Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of GRI Bio often depends not only on the future outlook of the potential GRI Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GRI Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6546.00 | |
| Cash And Short Term Investments | 5 M |
Other Information on Investing in GRI Etf
GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.